Top of this page
Skip navigation, go straight to the content

Our Company Magazine Detail

90 years of innovation, adaptation and progress

  • Posted by

    UCB is celebrating its 90th birthday. The company was founded by a family of entrepreneurs with a will to innovate. Today it is a strong and dynamic leader in neurology and immunology – and ready for the next 90 years.

    This landmark anniversary was celebrated at a glittering event in Brussels, attended by UCB leaders, past and present, as well as HRH Princess Astrid and Alexander De Croo, Deputy Prime Minister of Belgium. The event featured the presentation of a new book tracing UCB’s history over nine decades. A digital flipbook of this publication – UCB:The First 90 Years – is available online.

    Over the decades, the company has evolved and adapted, working hard to stay ahead of the curve. Having made it through economic hard times, a war and many other challenges, UCB has shown the resilience of its founders.

    Founded in 1928 by the Janssen family, UCB was originally a ‘hybrid’ company. Its focus was primarily on chemicals but also on pharmaceuticals. The company has undergone several transformations. The current chapter in UCB’s history has seen it transition from a hybrid to a global pharma company.

    Emmanuel Janssen would barely recognize the company today, yet it embodies his entrepreneurial spirit and passion for reinvention. UCB is now active in approximately 40 countries, focusing on immunology and neurology. Our medicines reach millions of patients in almost every corner of the globe.

    Our way of working has also changed over the past 90 years. Modern medicine is powered by networks. We are constantly forging networks, internally and externally, because we know that collaboration is the key to success. Together with academics, health professionals, patients, industry partners and others, we are committed to turning science into solutions for those who need them.

    We remain very conscious of our role and of our responsibility to help patients live the lives they want. Our goal is to deliver value to patients and to address unmet medical need. After all, what is the point of innovation if not to serve patients and their families?

    As we look ahead to the next 90 years, we continue to be Inspired by Patients. Driven by Science.

    Tags:
    Categories:
    Share:

Leave a Comment